Phase III Study Treatment of CLL B and C
NCT00535912
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Lymphocytic, Chronic
Interventions
PROCEDURE:
Stem cells autograft
Sponsor
French Innovative Leukemia Organisation